vs
GXO Logistics, Inc.（GXO）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是GXO Logistics, Inc.的1.6倍（$5.5B vs $3.5B），TENET HEALTHCARE CORP净利率更高（11.7% vs 1.2%，领先10.4%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 7.9%），TENET HEALTHCARE CORP自由现金流更多（$367.0M vs $115.0M），过去两年GXO Logistics, Inc.的营收复合增速更高（19.5% vs 1.5%）
GXO物流是总部位于美国康涅狄格州格林威治的全球化合同物流企业，为三十余个国家的蓝筹客户提供外包供应链管理、仓储及逆向物流服务，合作客户涵盖苹果、耐克、波音、惠而浦、雀巢等众多全球知名企业。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
GXO vs THC — 直观对比
营收规模更大
THC
是对方的1.6倍
$3.5B
营收增速更快
THC
高出1.1%
7.9%
净利率更高
THC
高出10.4%
1.2%
自由现金流更多
THC
多$252.0M
$115.0M
两年增速更快
GXO
近两年复合增速
1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $5.5B |
| 净利润 | $43.0M | $644.0M |
| 毛利率 | — | — |
| 营业利润率 | 2.7% | 15.4% |
| 净利率 | 1.2% | 11.7% |
| 营收同比 | 7.9% | 9.0% |
| 净利润同比 | -57.0% | 12.6% |
| 每股收益（稀释后） | $0.35 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GXOTHC
| Q4 25 | $3.5B | $5.5B | ||
| Q3 25 | $3.4B | $5.3B | ||
| Q2 25 | $3.3B | $5.3B | ||
| Q1 25 | $3.0B | $5.2B | ||
| Q4 24 | $3.3B | $5.1B | ||
| Q3 24 | $3.2B | $5.1B | ||
| Q2 24 | $2.8B | $5.1B | ||
| Q1 24 | $2.5B | $5.4B |
净利润GXOTHC
| Q4 25 | $43.0M | $644.0M | ||
| Q3 25 | $59.0M | $579.0M | ||
| Q2 25 | $26.0M | $522.0M | ||
| Q1 25 | $-96.0M | $622.0M | ||
| Q4 24 | $100.0M | $572.0M | ||
| Q3 24 | $33.0M | $681.0M | ||
| Q2 24 | $38.0M | $477.0M | ||
| Q1 24 | $-37.0M | $2.3B |
营业利润率GXOTHC
| Q4 25 | 2.7% | 15.4% | ||
| Q3 25 | 3.5% | 16.8% | ||
| Q2 25 | 2.7% | 15.6% | ||
| Q1 25 | -1.9% | 18.1% | ||
| Q4 24 | 3.1% | 16.2% | ||
| Q3 24 | 2.6% | 21.3% | ||
| Q2 24 | 2.6% | 14.9% | ||
| Q1 24 | -1.6% | 61.2% |
净利率GXOTHC
| Q4 25 | 1.2% | 11.7% | ||
| Q3 25 | 1.7% | 10.9% | ||
| Q2 25 | 0.8% | 9.9% | ||
| Q1 25 | -3.2% | 11.9% | ||
| Q4 24 | 3.1% | 11.3% | ||
| Q3 24 | 1.0% | 13.3% | ||
| Q2 24 | 1.3% | 9.3% | ||
| Q1 24 | -1.5% | 43.5% |
每股收益（稀释后）GXOTHC
| Q4 25 | $0.35 | $4.22 | ||
| Q3 25 | $0.51 | $3.86 | ||
| Q2 25 | $0.23 | $3.14 | ||
| Q1 25 | $-0.81 | $4.27 | ||
| Q4 24 | $0.83 | $3.79 | ||
| Q3 24 | $0.28 | $4.89 | ||
| Q2 24 | $0.32 | $2.64 | ||
| Q1 24 | $-0.31 | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $854.0M | $2.9B |
| 总债务越低越好 | $2.6B | $13.1B |
| 股东权益账面价值 | $3.0B | $4.2B |
| 总资产 | $12.3B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.88× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资GXOTHC
| Q4 25 | $854.0M | $2.9B | ||
| Q3 25 | $339.0M | $3.0B | ||
| Q2 25 | $205.0M | $2.6B | ||
| Q1 25 | $288.0M | $3.0B | ||
| Q4 24 | $413.0M | $3.0B | ||
| Q3 24 | $548.0M | $4.1B | ||
| Q2 24 | $469.0M | $2.9B | ||
| Q1 24 | $423.0M | $2.5B |
总债务GXOTHC
| Q4 25 | $2.6B | $13.1B | ||
| Q3 25 | $2.2B | $13.1B | ||
| Q2 25 | $2.6B | $13.1B | ||
| Q1 25 | $2.5B | $13.1B | ||
| Q4 24 | $2.5B | $13.1B | ||
| Q3 24 | $2.6B | $12.8B | ||
| Q2 24 | $2.6B | $12.8B | ||
| Q1 24 | $1.5B | $12.8B |
股东权益GXOTHC
| Q4 25 | $3.0B | $4.2B | ||
| Q3 25 | $3.0B | $4.0B | ||
| Q2 25 | $2.9B | $3.7B | ||
| Q1 25 | $2.9B | $4.2B | ||
| Q4 24 | $3.0B | $4.2B | ||
| Q3 24 | $3.1B | $3.8B | ||
| Q2 24 | $2.9B | $3.5B | ||
| Q1 24 | $2.9B | $3.5B |
总资产GXOTHC
| Q4 25 | $12.3B | $29.7B | ||
| Q3 25 | $11.9B | $29.4B | ||
| Q2 25 | $11.9B | $28.7B | ||
| Q1 25 | $11.3B | $29.2B | ||
| Q4 24 | $11.3B | $28.9B | ||
| Q3 24 | $11.9B | $29.4B | ||
| Q2 24 | $11.4B | $29.3B | ||
| Q1 24 | $9.4B | $28.9B |
负债/权益比GXOTHC
| Q4 25 | 0.88× | 3.10× | ||
| Q3 25 | 0.74× | 3.26× | ||
| Q2 25 | 0.88× | 3.49× | ||
| Q1 25 | 0.89× | 3.13× | ||
| Q4 24 | 0.84× | 3.14× | ||
| Q3 24 | 0.82× | 3.33× | ||
| Q2 24 | 0.88× | 3.67× | ||
| Q1 24 | 0.53× | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.0M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $115.0M | $367.0M |
| 自由现金流率自由现金流/营收 | 3.3% | 6.6% |
| 资本支出强度资本支出/营收 | 1.6% | 6.6% |
| 现金转化率经营现金流/净利润 | 3.95× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $2.5B |
8季度趋势，按日历期对齐
经营现金流GXOTHC
| Q4 25 | $170.0M | $731.0M | ||
| Q3 25 | $232.0M | $1.1B | ||
| Q2 25 | $3.0M | $936.0M | ||
| Q1 25 | $29.0M | $815.0M | ||
| Q4 24 | $186.0M | $-331.0M | ||
| Q3 24 | $198.0M | $1.0B | ||
| Q2 24 | $115.0M | $747.0M | ||
| Q1 24 | $50.0M | $586.0M |
自由现金流GXOTHC
| Q4 25 | $115.0M | $367.0M | ||
| Q3 25 | $88.0M | $778.0M | ||
| Q2 25 | $-44.0M | $743.0M | ||
| Q1 25 | $-49.0M | $642.0M | ||
| Q4 24 | $82.0M | $-661.0M | ||
| Q3 24 | $104.0M | $829.0M | ||
| Q2 24 | $27.0M | $602.0M | ||
| Q1 24 | $-23.0M | $346.0M |
自由现金流率GXOTHC
| Q4 25 | 3.3% | 6.6% | ||
| Q3 25 | 2.6% | 14.7% | ||
| Q2 25 | -1.3% | 14.1% | ||
| Q1 25 | -1.6% | 12.3% | ||
| Q4 24 | 2.5% | -13.0% | ||
| Q3 24 | 3.3% | 16.2% | ||
| Q2 24 | 0.9% | 11.8% | ||
| Q1 24 | -0.9% | 6.4% |
资本支出强度GXOTHC
| Q4 25 | 1.6% | 6.6% | ||
| Q3 25 | 4.2% | 5.3% | ||
| Q2 25 | 1.4% | 3.7% | ||
| Q1 25 | 2.6% | 3.3% | ||
| Q4 24 | 3.2% | 6.5% | ||
| Q3 24 | 3.0% | 4.2% | ||
| Q2 24 | 3.1% | 2.8% | ||
| Q1 24 | 3.0% | 4.5% |
现金转化率GXOTHC
| Q4 25 | 3.95× | 1.14× | ||
| Q3 25 | 3.93× | 1.83× | ||
| Q2 25 | 0.12× | 1.79× | ||
| Q1 25 | — | 1.31× | ||
| Q4 24 | 1.86× | -0.58× | ||
| Q3 24 | 6.00× | 1.53× | ||
| Q2 24 | 3.03× | 1.57× | ||
| Q1 24 | — | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GXO
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
